prednisolone has been researched along with Castleman Disease in 60 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Castleman Disease: Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is a systemic inflammatory disorder characterized by the above-mentioned symptoms." | 4.12 | TAFRO Syndrome That Responded to Prednisolone-only Treatment: Evaluating Changes in IL-6. ( Amano, K; Arinaga-Hino, T; Ida, H; Ide, T; Koga, H; Kuwahara, R; Nagafuji, K; Oshima, K; Sano, T; Shimasaki, Y; Suzuki, H; Torimura, T; Yamaguchi, M, 2022) |
| " In this report, we describe a case of disseminated cryptococcosis in a 55-year-old man who was receiving tocilizumab every 2 weeks along with daily prednisolone and cyclosporine for Castleman's disease." | 3.88 | Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease. ( Kamei, H; Nishioka, H; Takegawa, H, 2018) |
| "Hydroxychloroquine and steroid treatments were started after the operation." | 2.72 | Systemic lupus erythematosus complicated with Castleman disease: a case-based review. ( Aktay Ayaz, N; Demirkan, FG; Doğan, S; Kalyoncu Uçar, A; Sönmez, HE, 2021) |
| "The prednisolone dose was gradually tapered, then discontinued." | 2.72 | Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature. ( Dohi, K; Fujimoto, M; Hirabayashi, Y; Katayama, K; Murata, T; Nakajima, A; Oda, K; Saiki, R, 2021) |
| " Here we report a similar case of SLE combined with CD in a 23-year-old girl who displayed systemic symptoms, including systemic lymphadenopathy and abnormal laboratory findings indicating the active phase of SLE." | 2.48 | A case report of systemic lupus erythematosus combined with Castleman's disease and literature review. ( Chen, XY; Wang, HY; Xia, JY; Xu, F; Xue, J; Yang, Y, 2012) |
| "Multicentric Castleman's disease has a more aggressive clinical course with diffuse lymph node enlargement and systemic illness." | 2.44 | Multicentric Castleman's disease in two cases. ( Atri, S; Bagga, A; Kabra, SK; Karak, AK; Seth, R; Sharma, R; Thavaraj, V, 2007) |
| "Castleman disease is a rare cause of lymphoid hyperplasia and may result in localized symptoms or an aggressive, multisystem disorder." | 1.48 | Sjögren's and plasma cell variant Castleman disease: a case report. ( Abrahams, AD; Dei-Adomakoh, YA; Dey, DI; Quarcoopome, L; Segbefia, CI, 2018) |
| "Multicentric Castleman's disease (MCD) is a rare, non-malignant lymphoproliferative disorder." | 1.46 | Multicentric Castleman's disease with multiple hepatic mass lesions mimicking malignant liver tumors. ( Hiroshima, Y; Inoue, D; Kaiume, H; Kobayashi, H; Kojima, M; Masaki, Y; Nasuno, M; Sato, Y; Sumi, M; Ueki, T; Watanabe, M, 2017) |
| "Castleman disease is a rare lymphoproliferative disorder that has many presentations ranging from unifocal or multifocal mass lesions to a monoclonal gammopathy." | 1.40 | Papilledema as the initial presentation of Castleman disease. ( Jiang, H; Jing, Y; Tian, G; Wang, J; Zhang, X, 2014) |
| "Castleman's disease is a rare cause of lymphoid hyperplasia that may result in localized symptoms or an aggressive, multisystem disorder that can mimic other diseases like lymphoma or tuberculosis." | 1.39 | Multicentric Castleman's disease in a Ghanaian adult. ( Dei-Adomakoh, YA; Ekem, I; Segbefia, C; Taylor, A, 2013) |
| "The microscopic examination showed IgA nephropathy with crescent formation, accompanied by mild lymphoplasmacytic tubulointerstitial nephritis." | 1.37 | [Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease]. ( Fujii, A; Fujiwara, H; Ishimoto, Y; Kotera, N; Kurita, N; Mise, N; Sugimoto, T; Tanaka, M; Tanaka, S; Yamaguchi, Y, 2011) |
| "Mixed Connective Tissue Disorder with Castleman's Disease is a rare association; the patient presenting with varied and interesting manifestations." | 1.36 | Mixed connective tissue disorder and Castleman's disease. ( Boorugu, HK; Chrispal, A; Thomas, EM; Vasuki, Z, 2010) |
| "We have encountered an unusual case of Castleman's disease of the plasma cell type characterized by nephrotic syndrome because of glomerulopathy mimicking membranoproliferative glomerulonephritis." | 1.35 | A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis. ( Gasyu, I; Ito, J; Kashiwagi, A; Oka, K; Okazaki, T; Osawa, N; Sakaguchi, M; Sugimoto, T; Takeda, N; Tanaka, Y; Uzu, T, 2008) |
| "Glomeruloid hemangioma is a specific marker of POEMS syndrome and is related to Castleman's disease." | 1.35 | Glomeruloid hemangioma. ( Shikata, N; Takasu, K; Tsubura, A; Yamazaki, F; Yuri, T, 2008) |
| "We report three cases of multicentric Castleman's disease (MCD) successfully treated with anti-interleukin-6 receptor antibody (tocilizumab)." | 1.34 | Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. ( Goto, D; Ito, S; Mamura, M; Matsumoto, I; Matsuyama, M; Sumida, T; Suzuki, T; Tsuboi, H; Tsutsumi, A, 2007) |
| "Multicentric Castleman's disease (MCD) is an uncommon and often incurable lymphoproliferative disorder." | 1.32 | Multicentric Castleman's disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide. ( Fujii, K; Ichikado, K; Iyonaga, K; Muranaka, H; Suga, M; Yamaguchi, T, 2003) |
| "She was diagnosed with systemic juvenile idiopathic arthritis (JIA)." | 1.32 | Systemic juvenile idiopathic arthritis mimics multicentric Castleman's disease. ( Kano, G; Morimoto, A; Osone, S; Sugimoto, T; Todo, S; Tsutsui, J, 2003) |
| "Multicentric Castleman disease is a rare but distinct disorder that may present initially with ocular signs and symptoms." | 1.30 | Castleman disease presenting with ophthalmic signs and symptoms. ( Fujisawa, N; Kawaguchi, K; Kurokawa, T; Suzuki, S; Yoshimura, N, 1999) |
| "Treatment with prednisolone resulted in an improvement in the chest X-ray findings, as well as a diminished polyclonal hypergammaglobulin level." | 1.29 | Lymphoid interstitial pneumonia as a pulmonary lesion of idiopathic plasmacytic lymphadenopathy with hyperimmunoglobulinemia. ( Kawabata, Y; Miwa, T; Ogawa, K; Takagi, K; Torii, K; Yokoi, T, 1994) |
| "Treatment with prednisolone and melphalan resulted in improvement of clinical findings such as anemia, lymph node swelling and hypergammaglobulinemia in concurrence with decrease in serum levels of IL-6." | 1.29 | [Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6]. ( Hashimoto, S; Ishii, A; Kawano, E; Kogure, K; Matsuura, Y; Nakamura, H; Nakaseko, C; Nishimura, M; Oh, H; Yoshida, S, 1993) |
| "Anemia, hyperimmunoglobulinemia with hypo-albuminemia (no M-protein) and liver dysfunction were found." | 1.28 | Successful treatment of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia. ( Fujiwara, Y; Ohnishi, K; Tanabe, N; Tanaka, M; Uchida, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.33) | 18.7374 |
| 1990's | 10 (16.67) | 18.2507 |
| 2000's | 17 (28.33) | 29.6817 |
| 2010's | 24 (40.00) | 24.3611 |
| 2020's | 7 (11.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kaga, H | 1 |
| Kurahashi, H | 1 |
| Kubota, A | 1 |
| Hatano, Y | 1 |
| Nanjo, H | 1 |
| Wakui, H | 1 |
| Takahashi, N | 1 |
| Sugawara, E | 1 |
| Sato, T | 1 |
| Amasaki, Y | 1 |
| Katsumata, K | 1 |
| Suzuki, H | 1 |
| Sano, T | 1 |
| Shimasaki, Y | 1 |
| Yamaguchi, M | 1 |
| Ide, T | 1 |
| Arinaga-Hino, T | 1 |
| Kuwahara, R | 1 |
| Amano, K | 1 |
| Oshima, K | 1 |
| Nagafuji, K | 1 |
| Ida, H | 1 |
| Koga, H | 1 |
| Torimura, T | 1 |
| Yanagiya, R | 1 |
| Suzuki, T | 3 |
| Nakamura, S | 1 |
| Fujita, K | 1 |
| Oyama, M | 1 |
| Okuyama, A | 1 |
| Sugasawa, K | 1 |
| Nakayama, T | 1 |
| Suzuki, Y | 1 |
| Ishizawa, K | 1 |
| Saito, S | 1 |
| Arai, K | 1 |
| Mukae, J | 1 |
| Akiyama, M | 1 |
| Kumagai, J | 1 |
| Yamamoto, K | 2 |
| Demirkan, FG | 1 |
| Doğan, S | 1 |
| Kalyoncu Uçar, A | 1 |
| Sönmez, HE | 1 |
| Aktay Ayaz, N | 1 |
| Saiki, R | 1 |
| Katayama, K | 1 |
| Hirabayashi, Y | 1 |
| Oda, K | 1 |
| Fujimoto, M | 1 |
| Murata, T | 1 |
| Nakajima, A | 1 |
| Dohi, K | 1 |
| Yoshizaki, K | 1 |
| Ueki, T | 1 |
| Nasuno, M | 1 |
| Kaiume, H | 1 |
| Hiroshima, Y | 1 |
| Sumi, M | 1 |
| Watanabe, M | 1 |
| Inoue, D | 1 |
| Masaki, Y | 2 |
| Sato, Y | 1 |
| Kojima, M | 1 |
| Kobayashi, H | 2 |
| Nishioka, H | 1 |
| Takegawa, H | 1 |
| Kamei, H | 1 |
| Gu, L | 1 |
| Ye, S | 1 |
| Fujimoto, S | 1 |
| Kawabata, H | 1 |
| Kurose, N | 1 |
| Kawanami-Iwao, H | 1 |
| Sakai, T | 1 |
| Kawanami, T | 1 |
| Fujita, Y | 2 |
| Fukushima, T | 1 |
| Dei-Adomakoh, YA | 2 |
| Quarcoopome, L | 1 |
| Abrahams, AD | 1 |
| Segbefia, CI | 1 |
| Dey, DI | 1 |
| Goda, T | 1 |
| Oyama, N | 1 |
| Iwamoto, T | 1 |
| Uemura, J | 1 |
| Uchida, K | 1 |
| Kondo, E | 1 |
| Wada, H | 1 |
| Yagita, Y | 1 |
| Otsuka, M | 1 |
| Koga, T | 1 |
| Sumiyoshi, R | 1 |
| Okamoto, M | 1 |
| Endo, Y | 1 |
| Tsuji, S | 1 |
| Takatani, A | 1 |
| Shimizu, T | 2 |
| Igawa, T | 1 |
| Kawashiri, SY | 1 |
| Iwamoto, N | 1 |
| Ichinose, K | 1 |
| Tamai, M | 1 |
| Nakamura, H | 2 |
| Origuchi, T | 1 |
| Daisuke, N | 1 |
| Kawakami, A | 1 |
| Saghafi, H | 1 |
| Aghaali, M | 1 |
| Haghighi, S | 1 |
| Segbefia, C | 1 |
| Ekem, I | 1 |
| Taylor, A | 1 |
| Tian, G | 1 |
| Jing, Y | 1 |
| Jiang, H | 1 |
| Wang, J | 1 |
| Zhang, X | 1 |
| Hentrich, M | 1 |
| Hoffmann, C | 1 |
| Mosthaf, F | 1 |
| Müller, M | 1 |
| Siehl, J | 1 |
| Wyen, C | 1 |
| Hensel, M | 1 |
| Honda, Y | 1 |
| Tanizaki, H | 1 |
| Otsuka, A | 1 |
| Shirakashi, M | 1 |
| Imura, Y | 1 |
| Mimori, T | 1 |
| Miyachi, Y | 1 |
| Kabashima, K | 1 |
| Foster, DW | 1 |
| Ecker, AH | 1 |
| Zvolensky, MJ | 1 |
| Buckner, JD | 1 |
| Däster, S | 1 |
| Eppenberger-Castori, S | 1 |
| Hirt, C | 1 |
| Soysal, SD | 1 |
| Delko, T | 1 |
| Nebiker, CA | 1 |
| Weixler, B | 1 |
| Amicarella, F | 1 |
| Iezzi, G | 1 |
| Governa, V | 1 |
| Padovan, E | 1 |
| Mele, V | 1 |
| Sconocchia, G | 1 |
| Heberer, M | 1 |
| Terracciano, L | 1 |
| Kettelhack, C | 1 |
| Oertli, D | 1 |
| Spagnoli, GC | 1 |
| von Holzen, U | 1 |
| Tornillo, L | 1 |
| Droeser, RA | 1 |
| Zhu, W | 1 |
| Germain, C | 1 |
| Liu, Z | 1 |
| Sebastian, Y | 1 |
| Devi, P | 1 |
| Knockaert, S | 1 |
| Brohawn, P | 1 |
| Lehmann, K | 1 |
| Damotte, D | 1 |
| Validire, P | 1 |
| Yao, Y | 1 |
| Valge-Archer, V | 1 |
| Hammond, SA | 1 |
| Dieu-Nosjean, MC | 1 |
| Higgs, BW | 1 |
| Mendez, TL | 1 |
| De Chatterjee, A | 1 |
| Duarte, T | 1 |
| De Leon, J | 1 |
| Robles-Martinez, L | 1 |
| Das, S | 1 |
| Khurshid, SS | 1 |
| Siegel, JA | 1 |
| Kinney, KA | 1 |
| Prentoe, J | 1 |
| Verhoye, L | 1 |
| Velázquez Moctezuma, R | 1 |
| Buysschaert, C | 1 |
| Farhoudi, A | 1 |
| Wang, R | 1 |
| Alter, H | 1 |
| Meuleman, P | 1 |
| Bukh, J | 1 |
| Maejima, R | 1 |
| Uno, K | 1 |
| Iijima, K | 1 |
| Fujishima, F | 1 |
| Noguchi, T | 1 |
| Ara, N | 1 |
| Asano, N | 1 |
| Koike, T | 1 |
| Imatani, A | 1 |
| Shimosegawa, T | 1 |
| Man, S | 1 |
| Qiu, P | 1 |
| Li, J | 1 |
| Zhang, L | 1 |
| Gao, W | 1 |
| Taylor, DA | 1 |
| Perin, EC | 1 |
| Willerson, JT | 1 |
| Zierold, C | 1 |
| Resende, M | 1 |
| Carlson, M | 1 |
| Nestor, B | 1 |
| Wise, E | 1 |
| Orozco, A | 1 |
| Pepine, CJ | 1 |
| Henry, TD | 1 |
| Ellis, SG | 1 |
| Zhao, DX | 1 |
| Traverse, JH | 1 |
| Cooke, JP | 1 |
| Schutt, RC | 1 |
| Bhatnagar, A | 1 |
| Grant, MB | 1 |
| Lai, D | 1 |
| Johnstone, BH | 1 |
| Sayre, SL | 1 |
| Moyé, L | 1 |
| Ebert, RF | 1 |
| Bolli, R | 1 |
| Simari, RD | 1 |
| Cogle, CR | 1 |
| Pilleri, P | 1 |
| Joblin, C | 1 |
| Boulanger, F | 1 |
| Onaka, T | 1 |
| Morakinyo, MK | 1 |
| Chipinda, I | 1 |
| Hettick, J | 1 |
| Siegel, PD | 1 |
| Abramson, J | 1 |
| Strongin, R | 1 |
| Martincigh, BS | 1 |
| Simoyi, RH | 1 |
| Salehi, MM | 1 |
| Safarzadeh, MA | 1 |
| Sahraei, E | 1 |
| Nejad, SA | 1 |
| Morimoto, Y | 1 |
| Izumi, H | 1 |
| Yoshiura, Y | 1 |
| Tomonaga, T | 1 |
| Oyabu, T | 1 |
| Myojo, T | 1 |
| Kawai, K | 1 |
| Yatera, K | 1 |
| Shimada, M | 1 |
| Kubo, M | 1 |
| Kitajima, S | 1 |
| Kuroda, E | 1 |
| Kawaguchi, K | 2 |
| Sasaki, T | 1 |
| Windsor, LC | 1 |
| Jessell, L | 1 |
| Lassiter, T | 1 |
| Benoit, E | 1 |
| Thiessen, CE | 1 |
| Tofflemire, KL | 1 |
| Makielski, KM | 1 |
| Ben-Shlomo, G | 1 |
| Whitley, RD | 1 |
| Allbaugh, RA | 1 |
| Viu, J | 1 |
| Armengou, L | 1 |
| Ríos, J | 1 |
| Cesarini, C | 1 |
| Jose-Cunilleras, E | 1 |
| Margesin, R | 1 |
| Zhang, DC | 1 |
| Frasson, D | 1 |
| Brouchkov, A | 1 |
| Jung, WY | 1 |
| Lee, HJ | 1 |
| Jeon, CO | 1 |
| Liu, J | 1 |
| Li, F | 1 |
| Tang, XD | 1 |
| Ma, J | 1 |
| Mao, M | 1 |
| Wu, FZ | 1 |
| Bai, SJ | 1 |
| Liu, YY | 1 |
| Han, CX | 1 |
| Li, XX | 1 |
| Liu, Y | 1 |
| Song, YH | 1 |
| Wu, ZY | 1 |
| Wang, FY | 1 |
| Kang, N | 1 |
| Tanaka, KI | 1 |
| Kanazawa, I | 1 |
| Miyake, H | 1 |
| Yano, S | 1 |
| Amano, C | 1 |
| Ishikawa, N | 1 |
| Maruyama, R | 1 |
| Sugimoto, T | 4 |
| Yin, Q | 1 |
| Tao, Y | 1 |
| Zhu, X | 1 |
| Zhou, Y | 1 |
| He, X | 1 |
| Cheng, L | 1 |
| Huang, Y | 1 |
| Li, D | 1 |
| Rangachari, D | 1 |
| VanderLaan, PA | 1 |
| Le, X | 1 |
| Folch, E | 1 |
| Kent, MS | 1 |
| Gangadharan, SP | 1 |
| Majid, A | 1 |
| Haspel, RL | 1 |
| Joseph, LJ | 1 |
| Huberman, MS | 1 |
| Costa, DB | 1 |
| Moussavian, MR | 1 |
| Laschke, MW | 1 |
| Schlachtenberger, G | 1 |
| von Heesen, M | 1 |
| Wagner, M | 1 |
| Glanemann, M | 1 |
| Menger, MD | 1 |
| Kantarci, FE | 1 |
| Eren, R | 1 |
| Gündoğan, C | 1 |
| Huq, GE | 1 |
| Doğu, MH | 1 |
| Suyanı, E | 1 |
| Sato, K | 1 |
| Shinkuma, S | 1 |
| Fujimoto, K | 1 |
| Hatanaka, KC | 1 |
| Ujiie, H | 1 |
| Nomura, T | 1 |
| Abe, R | 1 |
| Matsuno, Y | 1 |
| Shimizu, H | 1 |
| Ito, J | 1 |
| Takeda, N | 1 |
| Gasyu, I | 1 |
| Okazaki, T | 1 |
| Sakaguchi, M | 1 |
| Osawa, N | 1 |
| Tanaka, Y | 1 |
| Oka, K | 1 |
| Uzu, T | 1 |
| Kashiwagi, A | 1 |
| Kumar, D | 1 |
| Gupta, A | 1 |
| Kumar, L | 1 |
| Karak, A | 1 |
| Thulkar, S | 1 |
| Rastogi, R | 1 |
| Bhatti, S | 1 |
| Xia, JY | 1 |
| Chen, XY | 1 |
| Xu, F | 1 |
| Yang, Y | 1 |
| Wang, HY | 1 |
| Xue, J | 1 |
| Chrispal, A | 1 |
| Vasuki, Z | 1 |
| Thomas, EM | 1 |
| Boorugu, HK | 1 |
| Takenaka, K | 1 |
| Takada, K | 1 |
| Kobayashi, D | 1 |
| Moriguchi, M | 1 |
| Harigai, M | 1 |
| Miyasaka, N | 1 |
| Fujiwara, H | 1 |
| Mise, N | 1 |
| Ishimoto, Y | 1 |
| Kotera, N | 1 |
| Tanaka, M | 2 |
| Tanaka, S | 1 |
| Kurita, N | 1 |
| Fujii, A | 1 |
| Yamaguchi, Y | 1 |
| Liu, DT | 1 |
| Shields, JA | 1 |
| Li, CL | 1 |
| Ng, HK | 1 |
| Lam, DS | 1 |
| Jing, L | 1 |
| Shan, Z | 1 |
| Yongchu, H | 1 |
| Xixue, C | 1 |
| Xuejun, Z | 1 |
| Baek, HJ | 1 |
| Kook, H | 1 |
| Han, DK | 1 |
| Shin, MG | 1 |
| Kim, HS | 1 |
| Hwang, TJ | 1 |
| Ben-Chetrit, E | 1 |
| Bnaya, A | 1 |
| Vernea, F | 1 |
| Somech, R | 1 |
| Ashkenazi, YJ | 1 |
| Weerasuriya, N | 1 |
| Ranasinghe, LM | 1 |
| Wijesiriwardene, IS | 1 |
| Fernando, DJ | 1 |
| Wu, Q | 1 |
| Jinde, K | 1 |
| Yanagi, H | 1 |
| Endoh, M | 1 |
| Sakai, H | 1 |
| Iyonaga, K | 1 |
| Ichikado, K | 1 |
| Muranaka, H | 1 |
| Fujii, K | 1 |
| Yamaguchi, T | 1 |
| Suga, M | 1 |
| Tomonari, A | 1 |
| Shirafuji, N | 1 |
| Tojo, A | 1 |
| Iseki, T | 1 |
| Ooi, J | 1 |
| Komiya, I | 1 |
| Tani, K | 1 |
| Asano, S | 1 |
| Senanayake, S | 1 |
| Kelly, J | 1 |
| Lloyd, A | 1 |
| Waliuzzaman, Z | 1 |
| Goldstein, D | 1 |
| Rawlinson, W | 1 |
| Osone, S | 1 |
| Morimoto, A | 1 |
| Tsutsui, J | 1 |
| Kano, G | 1 |
| Todo, S | 1 |
| Belletti, GA | 1 |
| Savio, V | 1 |
| Minoldo, D | 1 |
| Caminos, S | 1 |
| Yorio, MA | 1 |
| Kayasut, K | 1 |
| Le Tourneau, A | 1 |
| Rio, B | 1 |
| Bost-Bezeaud, F | 1 |
| Heuberger, L | 1 |
| Diebold, J | 1 |
| Audouin, J | 1 |
| Alizadeh, H | 1 |
| Kristenssen, J | 1 |
| El Teraifi, H | 1 |
| Malanin, K | 1 |
| Ohta, T | 1 |
| Furukawa, Y | 1 |
| Aoyama, Y | 1 |
| Kumura, T | 1 |
| Mugitani, A | 1 |
| Nakamae, H | 1 |
| Koh, K | 1 |
| Yamane, T | 1 |
| Hino, M | 1 |
| Matsuyama, M | 1 |
| Tsuboi, H | 1 |
| Ito, S | 1 |
| Mamura, M | 1 |
| Goto, D | 1 |
| Matsumoto, I | 1 |
| Tsutsumi, A | 1 |
| Sumida, T | 1 |
| Sharma, R | 1 |
| Seth, R | 1 |
| Thavaraj, V | 1 |
| Bagga, A | 1 |
| Kabra, SK | 1 |
| Karak, AK | 1 |
| Atri, S | 1 |
| Yuri, T | 1 |
| Yamazaki, F | 1 |
| Takasu, K | 1 |
| Shikata, N | 1 |
| Tsubura, A | 1 |
| Herrada, J | 1 |
| Cabanillas, FF | 1 |
| Torii, K | 1 |
| Ogawa, K | 1 |
| Kawabata, Y | 1 |
| Yokoi, T | 1 |
| Takagi, K | 1 |
| Miwa, T | 1 |
| Nanki, T | 1 |
| Tomiyama, J | 1 |
| Arai, S | 1 |
| Chan, TM | 1 |
| Cheng, IK | 1 |
| Wong, KL | 1 |
| Chan, KW | 1 |
| Yamashita, E | 1 |
| Sato, J | 1 |
| Fujino, Y | 1 |
| Shioya, S | 1 |
| Tokuhiro, H | 1 |
| Kigawada, R | 1 |
| Kasai, K | 1 |
| Nakaseko, C | 1 |
| Ishii, A | 1 |
| Kogure, K | 1 |
| Kawano, E | 1 |
| Hashimoto, S | 1 |
| Nishimura, M | 1 |
| Matsuura, Y | 1 |
| Oh, H | 1 |
| Yoshida, S | 1 |
| Okubo, R | 1 |
| Yoshida, T | 1 |
| Kimura, T | 1 |
| Okuma, K | 1 |
| Morioka, E | 1 |
| Kuno, S | 1 |
| Tamura, K | 1 |
| Suzumiya, A | 1 |
| Tsuboi, Y | 1 |
| Kurokawa, T | 1 |
| Suzuki, S | 1 |
| Fujisawa, N | 1 |
| Yoshimura, N | 1 |
| Caterino, M | 1 |
| Giglio, L | 1 |
| Finocchi, V | 1 |
| Crecco, M | 1 |
| Kato, Y | 1 |
| Mihara, H | 1 |
| Mizutani, Y | 1 |
| Kamijima, S | 1 |
| Tanaka, A | 1 |
| Takeda, H | 1 |
| Kato, R | 1 |
| Oguri, T | 1 |
| Tanabe, N | 1 |
| Uchida, T | 1 |
| Fujiwara, Y | 1 |
| Ohnishi, K | 1 |
| Toyoshima, T | 1 |
| Sezai, S | 1 |
| Marumo, K | 1 |
| Hirano, M | 1 |
| Iwase, T | 1 |
| Goto, H | 1 |
| Yoshikawa, M | 1 |
| Yamamura, M | 1 |
| Inazu, T | 1 |
| Kimura, K | 1 |
| Saga, T | 1 |
| Nakai, T | 1 |
| Miyabo, S | 1 |
| Domae, N | 1 |
| Hosokawa, Y | 1 |
| Hattori, T | 1 |
| Hukuta, M | 1 |
6 reviews available for prednisolone and Castleman Disease
| Article | Year |
|---|---|
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Asian People; B-Lymphocyte Subset | 2022 |
Systemic lupus erythematosus complicated with Castleman disease: a case-based review.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Castleman Disease; Diagnosis, Differential; Female; | 2021 |
Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Biopsy; Castleman Disease; Drug | 2021 |
A reference guide for management of Castleman disease.
Topics: Antibodies, Monoclonal, Humanized; Castleman Disease; Herpesvirus 8, Human; Humans; Japan; Practice | 2017 |
A case report of systemic lupus erythematosus combined with Castleman's disease and literature review.
Topics: Biopsy; Castleman Disease; Chest Pain; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemi | 2012 |
Multicentric Castleman's disease in two cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Castleman Disease; Child; Follow-Up | 2007 |
54 other studies available for prednisolone and Castleman Disease
| Article | Year |
|---|---|
Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report.
Topics: Anemia, Refractory; Antibodies, Monoclonal, Humanized; Biopsy; C-Reactive Protein; Castleman Disease | 2022 |
TAFRO Syndrome That Responded to Prednisolone-only Treatment: Evaluating Changes in IL-6.
Topics: C-Reactive Protein; Castleman Disease; Edema; Humans; Interleukin-6; Liver Cirrhosis; Prednisolone; | 2022 |
TAFRO Syndrome Presenting with Retroperitoneal Panniculitis-like Computed Tomography Findings at Disease Onset.
Topics: Aged; Antirheumatic Agents; Castleman Disease; Cyclophosphamide; Edema; Glucocorticoids; Humans; Mal | 2020 |
[Successful treatment of pure red cell aplasia complicated by multicentric Castleman disease with prednisolone].
Topics: Aged; Bone Marrow; Castleman Disease; Humans; Male; Prednisolone; Red-Cell Aplasia, Pure | 2020 |
Multicentric Castleman's disease with multiple hepatic mass lesions mimicking malignant liver tumors.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Castleman Disease; Diagnosis, Differential; Female; Humans; | 2017 |
Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Cast | 2018 |
Tocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Biopsy; Bronchiolitis Obliterans; Castleman Di | 2019 |
Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.
Topics: Adult; Castleman Disease; Diagnosis, Differential; Female; Glucocorticoids; Humans; Prednisolone; Sj | 2017 |
Sjögren's and plasma cell variant Castleman disease: a case report.
Topics: Adult; Anemia, Hemolytic; Castleman Disease; Chlorambucil; Diagnosis, Differential; Drug Therapy, Co | 2018 |
A case of cerebral infarction in a patient with TAFRO syndrome.
Topics: Adolescent; Anti-Inflammatory Agents; Castleman Disease; Cerebral Infarction; Humans; Male; Predniso | 2019 |
Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report.
Topics: Adult; Arthritis; Arthritis, Rheumatoid; Castleman Disease; Chemokine CXCL10; Diagnosis, Differentia | 2019 |
Parapharengeal unicentric Castleman disease with nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Adult; Biopsy; Castleman Disease; Edema; Humans; Hypertension; Magnetic Res | 2013 |
Multicentric Castleman's disease in a Ghanaian adult.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cast | 2013 |
Papilledema as the initial presentation of Castleman disease.
Topics: Adult; Antineoplastic Agents; Castleman Disease; Cyclophosphamide; Doxorubicin; Female; Humans; Lymp | 2014 |
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 2014 |
Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Castleman | 2015 |
Topics: Acid-Base Imbalance; Acidosis, Renal Tubular; Aged; Air Pollution, Indoor; Amino Acid Substitution; | 2015 |
A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
Topics: Antiviral Agents; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Gancicl | 2016 |
Late-onset skin involvement on the forehead in multicentric Castleman disease.
Topics: Adult; Castleman Disease; Female; Follow-Up Studies; Forehead; Humans; Prednisolone; Rare Diseases; | 2017 |
A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis.
Topics: Adrenal Cortex Hormones; Castleman Disease; Diagnosis, Differential; Female; Glomerulonephritis; Glo | 2008 |
Unusual presentation of hyaline vascular Castleman's disease.
Topics: Adult; Anti-Inflammatory Agents; Castleman Disease; Female; Humans; Hyalin; Prednisolone; Vascular D | 2008 |
Multicentric hyaline-vascular type Castleman disease presenting as an epidural mass causing paraplegia: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Castleman Disease; Cyclophosphamide; | 2009 |
Mixed connective tissue disorder and Castleman's disease.
Topics: Adolescent; Azathioprine; Biopsy; Castleman Disease; Female; Glomerulonephritis, Membranoproliferati | 2010 |
A case of IgG4-related disease with features of Mikulicz's disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman's disease.
Topics: Biopsy; Castleman Disease; Diagnosis, Differential; Glucocorticoids; Humans; Immunoglobulin G; Immun | 2011 |
[Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease].
Topics: Castleman Disease; Glomerulonephritis, IGA; Humans; Interleukin-6; Male; Methylprednisolone; Middle | 2011 |
Hypertensive choroidopathy in Castleman's disease.
Topics: Adult; Castleman Disease; Choroid Diseases; Diagnosis, Differential; Female; Fluorescein Angiography | 2011 |
Successful treatment of a paraneoplastic pemphigus in a teenager using plasmapheresis, corticosteroids and tumour resection.
Topics: Adolescent; Castleman Disease; Female; Glucocorticoids; Humans; Paraneoplastic Syndromes; Pemphigus; | 2011 |
Unicentric Castleman disease relapsed after rituximab-CHOP chemotherapy or radiation therapy in an adolescent.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Sometimes double negative is positive.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Au | 2013 |
Castleman's disease with autoimmune haemolytic anaemia, subfertility and meningomyelocele.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Castleman Disease; Female; Humans; M | 2001 |
Acute interstitial nephritis with polyclonal B cell infiltration and development of mantle cell lymphoma.
Topics: Acute Disease; Aged; B-Lymphocytes; Castleman Disease; Chemotaxis, Leukocyte; Diagnosis, Differentia | 2002 |
Multicentric Castleman's disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide.
Topics: Biopsy, Needle; Bronchoalveolar Lavage Fluid; Castleman Disease; Cyclophosphamide; Dose-Response Rel | 2003 |
Acute myelogenous leukemia M5b developed during clinical remission of Castleman disease.
Topics: Antineoplastic Agents, Hormonal; Bone Marrow; Castleman Disease; Fatal Outcome; Humans; Leukemia, Mo | 2003 |
Multicentric Castleman's disease treated with antivirals and immunosuppressants.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antiviral Agents; Castleman Disea | 2003 |
Systemic juvenile idiopathic arthritis mimics multicentric Castleman's disease.
Topics: Arthritis, Juvenile; Biopsy, Needle; Castleman Disease; Child; Diagnosis, Differential; Drug Adminis | 2003 |
[Castleman disease].
Topics: Aged; Antineoplastic Agents, Hormonal; Biopsy; Castleman Disease; Diagnosis, Differential; Female; H | 2004 |
Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?
Topics: Aged; Antineoplastic Agents, Hormonal; Castleman Disease; Diagnosis, Differential; Humans; Male; Pla | 2006 |
Urticarial vasculitis and Castleman's disease.
Topics: Adult; Anti-Inflammatory Agents; Castleman Disease; Glucocorticoids; Humans; Male; Prednisolone; Rec | 2007 |
[Multicentric Castleman disease-like case characterized by lymphadenopathy and polyclonal hypergammaglobulinemia associated with so-called Mikulicz disease].
Topics: Aged; Castleman Disease; Diagnosis, Differential; Humans; Hypergammaglobulinemia; Immunoglobulin G; | 2007 |
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Castleman Disease; Dose-Response R | 2007 |
Glomeruloid hemangioma.
Topics: Biomarkers, Tumor; Castleman Disease; Female; Hemangioma; Humans; Lymph Nodes; Middle Aged; Parotid | 2008 |
Multicentric Castleman's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Combined Modality Therapy; | 1995 |
Lymphoid interstitial pneumonia as a pulmonary lesion of idiopathic plasmacytic lymphadenopathy with hyperimmunoglobulinemia.
Topics: Aged; Blood Gas Analysis; Castleman Disease; Humans; Hypergammaglobulinemia; Lung; Lung Diseases, In | 1994 |
Mixed connective tissue disease associated with multicentric Castleman's disease.
Topics: Castleman Disease; Female; HLA-DR4 Antigen; Humans; Interleukin-6; Middle Aged; Mixed Connective Tis | 1994 |
Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease).
Topics: Adult; Azathioprine; Biopsy; Castleman Disease; Complement System Proteins; Cyclophosphamide; Drug T | 1993 |
[A case of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia].
Topics: Adult; Castleman Disease; Female; Humans; Hypergammaglobulinemia; Immunoglobulin A; Immunoglobulin G | 1993 |
[Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6].
Topics: Aged; Castleman Disease; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 7; Humans; Interleuki | 1993 |
[Case of systemic Castleman's disease with hypothyroidism].
Topics: Anti-Inflammatory Agents; Castleman Disease; Cyclophosphamide; Female; Humans; Hypothyroidism; Immun | 1999 |
Castleman disease presenting with ophthalmic signs and symptoms.
Topics: Aged; Aspergillosis; Castleman Disease; Cytomegalovirus Infections; Diplopia; Eyelid Diseases; Fatal | 1999 |
[Current role of computerized tomography in the diagnosis and follow-up of Castleman's disease. Evaluating 2 mixed-variety cases].
Topics: Adult; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Ant | 2000 |
Ticlopidine treatment in idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia accompanied by nephrotic syndrome.
Topics: Adult; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hypergammaglo | 1992 |
Successful treatment of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia.
Topics: Castleman Disease; Edema; Eyelid Diseases; Humans; Hypergammaglobulinemia; Lymphatic Diseases; Male; | 1992 |
[A case of idiopathic plasmacytic lymph-adenopathy with polyclonal hyperimmunoglobulinemia (IPL) associated with pleural and peritoneal chylous effusion].
Topics: Castleman Disease; Chylothorax; Chylous Ascites; Humans; Hypergammaglobulinemia; Immunoglobulin A; I | 1989 |
[A case of multicentric angiofollicular lymph-node hyperplasia].
Topics: Castleman Disease; Drug Therapy, Combination; Female; Humans; Middle Aged; Prednisolone; Vincristine | 1987 |